Montalto G, Zignego A L, Ruggeri M I, Giannini C, Soresi M, Monti M, Carroccio A, Careccia G, Di Martino D, Giannelli F
Cattedra di Medicina Interna, Università di Palermo, Italy.
Dig Dis Sci. 1997 Aug;42(8):1703-7. doi: 10.1023/a:1018813532098.
In this study we aimed to correlate liver histology and the presence of hepatitis C virus (HCV) viremia, genotype, and quantity of HCV genome in 19 positive and 11 RIBA II indeterminate patients presenting persistently normal ALT values over 24 months before biopsy. In addition, after biopsy serum ALT values were monitored monthly for a mean follow-up period of 24.8 months, after which patients were reevaluated for RIBA II and the presence of viremia. Sixteen patients (53%) were serum HCV-RNA-positive; 13 of them (68%) were confirmed positive and 3 (27%) indeterminate on RIBA II. Histology of the HCV-RNA-positive patients showed eight cases of CPH (one case of genotype 1a; four cases type 1b; three cases type 2), six cases of CAH (three cases type 1b, three cases type 2), one case of CLH (type not determined), and one case of normal liver (NL) (type 1b). Histology of the HCV-RNA-negative patients showed four cases of CPH, one case of CAH, two cases of CLH, and seven cases of NL. During the follow-up period nine patients (30%) presented slight increases in ALT values (< 2 x N), and in particular, flares of ALT were observed four times in the CAH and five times in the CPH patients, who were all viremic, but never in the NL subjects. These results indicate that subjects positive on RIBA II, but with persistently normal ALT values, had a high probability of being serum HCV-RNA-positive and that almost all these viremic subjects presented histologic signs of liver disease. In contrast, RIBA II indeterminate subjects had a moderate probability of being HCV-RNA-positive, but a number of these may present signs of liver disease. In both cases there was no association with genotype or HCV-RNA serum levels. The other nonviremic cases included subjects with hepatic changes going toward resolution or with normal liver in whom hepatic biopsy can be avoided. Only one case was a true carrier since he was viremic with normal liver and persistently normal ALT values.
在本研究中,我们旨在关联19例丙型肝炎病毒(HCV)血症阳性和11例重组免疫印迹试验(RIBA)II结果不确定的患者的肝脏组织学情况,以及活检前24个月内丙氨酸氨基转移酶(ALT)值持续正常的患者的HCV病毒血症、基因型和HCV基因组数量。此外,活检后每月监测血清ALT值,平均随访期为24.8个月,之后对患者进行RIBA II和病毒血症情况的重新评估。16例患者(53%)血清HCV-RNA阳性;其中13例(68%)RIBA II确诊阳性,3例(27%)RIBA II结果不确定。HCV-RNA阳性患者的组织学表现为8例慢性持续性肝炎(CPH)(1例1a基因型;4例1b基因型;3例2基因型),6例慢性活动性肝炎(CAH)(3例1b基因型,3例2基因型),1例肝硬化(CLH)(未确定类型),1例正常肝脏(NL)(1b基因型)。HCV-RNA阴性患者的组织学表现为4例CPH,1例CAH,2例CLH和7例NL。在随访期间,9例患者(30%)ALT值略有升高(<2倍正常值),特别是,CAH患者中观察到4次ALT波动,CPH患者中观察到5次,这些患者均有病毒血症,但NL患者中未观察到。这些结果表明,RIBA II阳性但ALT值持续正常的患者血清HCV-RNA阳性的可能性很高,并且几乎所有这些有病毒血症的患者都有肝脏疾病的组织学表现。相比之下,RIBA II结果不确定的患者HCV-RNA阳性的可能性中等,但其中一些患者可能有肝脏疾病的表现。在这两种情况下,均与基因型或血清HCV-RNA水平无关。其他无病毒血症的病例包括肝脏病变趋于缓解的患者或肝脏正常的患者,对于这些患者可以避免进行肝活检。只有1例是真正的携带者,因为他有病毒血症,肝脏正常且ALT值持续正常。